Doxorubicin Adverse Reaction: Clinical Trials

4 trials for Doxorubicin Adverse Reaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed, 1 unknown. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Unknown 1
Not applicable1Not yet recruiting 1

Follow Doxorubicin Adverse Reaction: new trials by email Literature Review of Doxorubicin Adverse Reaction trials Research Report on Doxorubicin Adverse Reaction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Acupuncture - Febrile Neutropenia, Sarcoma
Not applicableNot yet recruitingShaare Zedek Medical Center602026-12-012026-04-29
The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity
Nicorandil Oral Tablet, Adriamycin (Doxorubicin) - Doxorubicin Induced Cardiotoxicity, Doxorubicin Induced Cardiomyopathy
Phase 2Not yet recruitingUniversiti Sains Malaysia1462026-12-012026-11-03
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Control group:DH001 placebo, Trial group: DH001 low-dose group, Trial group: DH001 high-dose group - Cancer, Heart Failure
Phase 2UnknownMonyan Pharmaceutical (Shanghai) Co., Ltd.902023-04-042023-10-23
The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor
Doxorubicin Adverse Reaction, Cardiomyopathies, Secondary
CompletedRush University Medical Center422017-01-172021-04-27

Narrower conditions

Cardiomyopathies (2)  ·  Heart Failure (2)  ·  Arrhythmias, Cardiac (1)  ·  Breast Neoplasms (1)  ·  Cardiotoxicity (1)  ·  Cross Infection (1)  ·  Febrile Neutropenia (1)  ·  Neoplasms (1)  ·  Sarcoma (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Neoplasms (2)  ·  Agranulocytosis (1)  ·  Breast Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Cytopenia (1)  ·  Disease Attributes (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Iatrogenic Disease (1)  ·  Infections (1)

Interventions

Acupuncture Therapy (1)  ·  Control Groups (1)  ·  Doxorubicin (1)  ·  Nicorandil (1)  ·  Population Groups (1)

Sponsors

Monyan Pharmaceutical (Shanghai) Co., Ltd. (1)  ·  Rush University Medical Center (1)  ·  Shaare Zedek Medical Center (1)  ·  Universiti Sains Malaysia (1)

Countries

China (1)  ·  Egypt (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Ayman A G, Prof (1)  ·  Hesheng He (1)  ·  Hongmei Jing (1)  ·  Hui Zhou (1)  ·  Jiwei Liu (1)  ·  Jun Zhu (1)  ·  Noah Samuels, MD (1)  ·  Noha S Abdelaziz, PhD (1)  ·  Nur H Md, lecturer (1)  ·  Sabariah N H, Ass.Prof (1)  ·  Tochi Okwuosa, DO, FACC (1)  ·  Wenbin Qian (1)  ·  Xiaojia Wang (1)  ·  Yufu Li (1)  ·  Zeping Zhou (1)